Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $549.54 | 11 | 87.2% |
| Education | $80.34 | 2 | 12.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $207.52 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $134.55 | 4 | $0 (2017) |
| Jazz Pharmaceuticals Inc. | $110.11 | 1 | $0 (2020) |
| Allergan Inc. | $83.86 | 4 | $0 (2019) |
| ITI, Inc. | $48.84 | 1 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $45.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $207.52 | 2 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($207.52) |
| 2023 | $48.84 | 1 | ITI, Inc. ($48.84) |
| 2020 | $110.11 | 1 | Jazz Pharmaceuticals Inc. ($110.11) |
| 2019 | $97.36 | 4 | Allergan Inc. ($52.36) |
| 2018 | $31.50 | 1 | Allergan Inc. ($31.50) |
| 2017 | $134.55 | 4 | Otsuka America Pharmaceutical, Inc. ($134.55) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $111.37 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $96.15 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2023 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2020 | Jazz Pharmaceuticals Inc. | SUNOSI (Drug) | Food and Beverage | In-kind items and services | $110.11 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2019 | Ironshore Pharmaceuticals Inc. | Jornay PM 20mg capsules (Bottle of 100) (Drug) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Central nervous system (CNS) stimulant | ||||||
| 09/27/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: NEUROSCIENCE | ||||||
| 02/13/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $31.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: PSYCHIATRY | ||||||
| 08/18/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/31/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 137 | 458 | $86,500 | $21,183 |
| 2022 | 4 | 149 | 442 | $80,195 | $20,492 |
| 2021 | 5 | 133 | 449 | $65,230 | $22,682 |
| 2020 | 4 | 134 | 429 | $57,720 | $18,178 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 227 | $43,650 | $10,651 | 24.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 51 | 169 | $29,550 | $7,029 | 23.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2023 | 30 | 62 | $13,300 | $3,502 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 181 | $34,700 | $8,958 | 25.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 48 | 147 | $25,250 | $6,525 | 25.8% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2022 | 25 | 70 | $13,725 | $3,867 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 44 | $6,520 | $1,142 | 17.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 129 | $20,400 | $8,199 | 40.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 40 | 172 | $26,225 | $7,843 | 29.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 99 | $11,230 | $3,581 | 31.9% |
| 90836 | Psychotherapy with evaluation and management visit, 45 minutes | Office | 2021 | 11 | 32 | $5,675 | $2,086 | 36.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 17 | $1,700 | $973.27 | 57.3% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 43 | 178 | $26,500 | $8,827 | 33.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 40 | 138 | $14,960 | $4,544 | 30.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 93 | $14,500 | $3,920 | 27.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 11 | 20 | $1,760 | $887.99 | 50.5% |
About Dr. Michael Webb, M.D
Dr. Michael Webb, M.D is a Psychiatry healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154451318.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Webb, M.D has received a total of $629.88 in payments from pharmaceutical and medical device companies, with $207.52 received in 2024. These payments were reported across 13 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($549.54).
As a Medicare-enrolled provider, Webb has provided services to 553 Medicare beneficiaries, totaling 1,778 services with total Medicare billing of $82,536. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Eugene, OR
- Active Since 03/06/2007
- Last Updated 01/23/2008
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154451318
Products in Payments
- CAPLYTA (Drug) $256.36
- REXULTI (Drug) $134.55
- SUNOSI (Drug) $110.11
- VRAYLAR (Drug) $83.86
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $45.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Eugene
Dr. John Lipkin, M.d, M.D
Psychiatry — Payments: $15,260
Dr. Hernan Schmidt, M.d, M.D
Psychiatry — Payments: $6,567
Victor Richenstein, Md, MD
Psychiatry — Payments: $5,106
Veronica Alfero, Md, MD
Psychiatry — Payments: $2,017
Dr. Franc Strgar, M.d, M.D
Psychiatry — Payments: $1,445
Dr. Russell Geoffrey, Md, MD
Psychiatry — Payments: $1,378